Fred Kerwood

Fred has over 30 years of program management and clinical operations experience in the pharmaceutical industry. Before joining Celcuity, Fred was VP of Clinical Operations at CytomX Therapeutics where he oversaw the execution of their oncology programs, including a Phase 2 program in breast cancer. Prior to CytomX, Fred was with the immuno-oncology company Immune Design, a subsidiary of Merck, where he was the VP of Project Management and Clinical Operations. Fred also spent 10 years at Johnson & Johnson, where he served in various program management, new product development and strategic marketing roles. He has an MBA in science and technology from LaSalle University and a BS degree in psychology / biochemistry from Texas A&M University.